For instance, transcription factor AP-1 promotes the expression of PD-L1 in Hodgkin lymphomas by binding to the AP-1-responsive enhancer in the PD-L1 gene14, and HIF-2α targeted PD-L1 in renal cell carcinoma15. This evidence concerns the gene CD274 and Hodgkins lymphoma.